Researchers at Yale School of Medicine have successfully treated patients with moderate to severe eczema using a rheumatoid arthritis drug recently shown to reverse two other disfiguring skin conditions, vitiligo and alopecia areata. The study is evidence...
Nearly one in four patients with chronic hepatitis C (HCV) are denied initial approval for a drug therapy that treats the most common strain of the infection, according to a Yale School of Medicine study.The finding, published Aug. 27 in PLOS ONE,...
Yale researchers found that the current definition of acute kidney injury may be causing patients without the condition to be misclassified.Dr. F. Perry WilsonTheir research, published in the Clinical Journal of the American Society of Nephrology,...
